We are live on ! Find out more
KRON

Kronos Bio
KRON

Delisted

KRON was delisted on the 20th of June, 2025.

Back to rankings

72 hedge funds and large institutions have $1.01B invested in Kronos Bio in 2020 Q4 according to their latest regulatory filings, with 72 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

60.89% more ownership

Funds ownership: 0% → 60.89% (+61%)

Holders
72
Holders Change
+72
Holders Change %
–
% of All Funds
1.27%
Holding in Top 10
4
Holding in Top 10 Change
+4
Holding in Top 10 Change %
% of All Funds
0.07%
New
72
Increased
–
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
OFM
Omega Fund Management
Massachusetts
+$120M
2
Capital Research Global Investors
Capital Research Global Investors
California
+$111M
3
PA
Perceptive Advisors
New York
+$87.2M
4
VVA
Vida Ventures Advisors
Massachusetts
+$86.8M
5
Fidelity Investments
Fidelity Investments
Massachusetts
+$80.6M

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
DP
26
DSAM Partners
United Kingdom
$5.98M +$6.28M +200,096 New
Franklin Resources
27
Franklin Resources
California
$5.97M +$6.28M +200,008 New
Northern Trust
28
Northern Trust
Illinois
$5.07M +$5.33M +169,827 New
OCA
29
Octagon Capital Advisors
New York
$4.37M +$4.59M +146,173 New
Morgan Stanley
30
Morgan Stanley
New York
$3.34M +$3.51M +111,812 New
Alyeska Investment Group
31
Alyeska Investment Group
Illinois
$2.99M +$3.14M +100,000 New
PAMU
32
Pictet Asset Management (UK)
United Kingdom
$2.92M +$3.07M +97,909 New
Charles Schwab
33
Charles Schwab
California
$2.73M +$2.87M +91,341 New
Millennium Management
34
Millennium Management
New York
$1.7M +$1.78M +56,828 New
N
35
Nuveen
North Carolina
$1.59M +$1.67M +53,295 New
Ameriprise
36
Ameriprise
Minnesota
$1.31M +$1.37M +43,790 New
Goldman Sachs
37
Goldman Sachs
New York
$1.27M +$1.33M +42,531 New
Bank of New York Mellon
38
Bank of New York Mellon
New York
$1.12M +$1.17M +37,367 New
SFM
39
Sphera Funds Management
Israel
$1.04M +$1.1M +35,000 New
California Public Employees Retirement System
40
California Public Employees Retirement System
California
$886K +$930K +29,652 New
TD Asset Management
41
TD Asset Management
Ontario, Canada
$885K +$929K +29,612 New
RCM
42
Ratan Capital Management
Florida
$695K +$730K +23,278 New
California State Teachers Retirement System (CalSTRS)
43
California State Teachers Retirement System (CalSTRS)
California
$660K +$693K +22,100 New
CCM
44
CAAS Capital Management
New York
$448K +$471K +15,000 New
HighTower Advisors
45
HighTower Advisors
Illinois
$448K +$471K +15,000 New
Norges Bank
46
Norges Bank
Norway
$448K +$471K +15,000 New
RhumbLine Advisers
47
RhumbLine Advisers
Massachusetts
$393K +$413K +13,156 New
ZP
48
Zimmer Partners
New York
$373K +$392K +12,500 New
D.E. Shaw & Co
49
D.E. Shaw & Co
New York
$359K +$377K +12,027 New
New York State Common Retirement Fund
50
New York State Common Retirement Fund
New York
$341K +$358K +11,400 New
1
2
3

KRON Hedge Fund Activity: Q4 2020 in Review

72 of the 5,652 institutional investors tracked by Wall St. Rank reported a position in Kronos Bio (KRON) for Q4 2020, worth a combined $1.01B.

Buyers outnumbered sellers: 72 funds opened new KRON positions and 0 closed out — a net gain of 72 holders — while 0 added to existing stakes and 0 trimmed.

The largest buyer was Omega Fund Management, opening a new position worth an estimated $120M.

  • 72 institutional investors held Kronos Bio (KRON) as of Q4 2020, up from 0 in Q3 2020.
  • Funds reported $1.01B of Kronos Bio stock for Q4 2020.
  • 72 funds opened new Kronos Bio positions in Q4 2020 and 0 closed out, a net change of +72 holders.
  • The largest Kronos Bio buyer in Q4 2020 was Omega Fund Management, an estimated $120M added.

Based on aggregated 13F filings for Q4 2020.